Dr. Fojo is currently a professor of medicine at Columbia University Irving Medical Center and the co-director of the Columbia Adrenal Surgery Center. Known for his research toward reversing cancer chemotherapy resistance, Dr. Fojo’s work in tumor growth kinetics (TGK) has been instrumental in advancing the field. Dr. Fojo’s expertise in adrenocortical cancer, thyroid cancer, and neuroendocrine malignancies — coupled with his involvement in the design, management, and interpretation of clinical trials — makes him particularly passionate about developing additional therapies and expanding treatment options for patients with these cancers.
Antonio Tito Fojo, MD
Co-Director, Adrenal Center
Scientific Advisory Board
Daniel D Von Hoff, M.D., F.A.C.P.
Chairman
Physician in Chief and Director of Translational Research at TGen. Chief Scientific Officer for US Oncology and for HonorHealth Clinical… Read More
David Sidransky, M.D.
Director of the Head and Neck Cancer Research at Johns Hopkins School of Medicine and Professor of Oncology, Otolaryngology, Cellular… Read More
Elliot Fishman, M.D.
Director of Diagnostic Imaging and Body Computed Tomography (CT) in the Russell H. Morgan Department of Radiology and Radiological Science,… Read More